Actinomycin D versus etoposide, methotrexate, actinomycin D/cyclophosphamide, and vincristine as second-line treatment in low-risk gestational trophoblastic neoplasia with primary methotrexate resistance
Authors:
- Mariza Branco-SilvaMBMariza Branco-Silva
- Firas CharfareFCFiras Charfare
- Ehsan GhoraniEGEhsan Ghorani
- Naveed SarwarNSNaveed Sarwar
- Baljeet KaurBKBaljeet Kaur
- Reece CaldwellRCReece Caldwell
- Lea GhataoreLGLea Ghataore
- Izildinha MaestaIMIzildinha Maesta
- Michael J. SecklMSMichael J. Seckl
- 30 July 2026
- journal article
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 36 (11)
Abstract
No abstract availableFunding Information
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2024/02607-4)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2018/10698-9)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (Finance Code 001)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES-PRINT 88887. 936593/2024-0)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES-PROEX 88887.824444/2023-00)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES-PRINT - 88887.936692/2024-00)
This publication has 21 references indexed in Scilit:
- Current and future treatments for low-risk gestational trophoblastic neoplasiaAnnals of Oncology, 2025
- Diagnosis and management of gestational trophoblastic disease: 2025 updateInternational Journal of Gynecology & Obstetrics, 2025
- Efficacy and safety of biweekly single-dose actinomycin D versus multiday methotrexate in low-risk gestational trophoblastic neoplasia: a prospective multicenter randomized trialAnnals of Oncology, 2025
- Treatment of low-risk gestational trophoblastic neoplasiaBest Practice & Research Clinical Obstetrics & Gynaecology, 2021
- Increasing the human chorionic gonadotrophin cut-off to ≤1000 IU/l for starting actinomycin D in post-molar gestational trophoblastic neoplasia developing resistance to methotrexate spares more women multi-agent chemotherapyESMO Open, 2021
- Practical clinical guidelines of the EOTTD for treatment and referral of gestational trophoblastic diseaseEuropean Journal of Cancer, 2020
- Treatment outcomes for 618 women with gestational trophoblastic tumours following a molar pregnancy at the Charing Cross Hospital, 2000–2009British Journal of Cancer, 2012
- Gestational trophoblastic diseaseThe Lancet, 2010
- Methotrexate for 2000 FIGO low-risk gestational trophoblastic neoplasia patients: efficacy and toxicityAmerican Journal of Obstetrics and Gynecology, 2009
- Single-dose actinomycin-D treatment for nonmetastatic gestational trophoblastic disease: A prospective phase II trial of the gynecologic oncology groupCancer, 1987